FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Social media erupts after Mamdani’s far-left supporters turn on him over homeless shelter: ‘Oops’

Virginia’s map war lays bare state’s sharp partisan turn as legal fight looms

Elite school teacher known as ‘Mr Wonderful’ accused of heinous crimes against students

Bombshell New Photos Change the Story for Patriots Coach Mike Vrabel, Move Timeline Years Earlier

Trump Cabinet member scraps Obama-era gender identity housing rule, cites ‘biological reality’

Prominent UFO Researcher Dies in Colorado

ICE nabs illegal aliens convicted of child sex crimes and meth trafficking in nationwide enforcement sweep

Former North Carolina police officer arrested for allegedly planning mass shooting at New Orleans festival

Long Island PTA mom accused of stealing $50K from elementary school while she served as NYPD officer

‘Storage Wars’ Star Darrell ‘The Gambler’ Sheets Found Dead in His Home

Former AG Tells CNN’s Tapper: VA Supreme Court Likely to Invalidate Redistricting Referendum, Possibly 7-0

Todd Blanche targets record denaturalizations in citizenship fraud crackdown

RFK Jr. Blasts Canada’s ‘Abhorrent’ Assisted Suicide Laws: US Can’t Be ‘Moral Society’ by Embracing Them

‘Lame duck’: Jeffries rips DeSantis after Florida invitation as redistricting fight heats up

Transgender Arrested for Allegedly Kidnapping Child and Taking Him Overseas for Gender Surgery

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”